Spironolactone Tablet, Film Coated
Product Images NDC 63629-1067

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-1067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

FDA Label Image

Figure 1 (Spironolactone 02)

FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
This text appears to be data related to a medical study on Diabetes, possibly evaluating the effectiveness of Spironolactone as compared to Placebo with respect to the variables mentioned such as Creatinine, Potassium, and Beta Blocker. However, without more context or information it is difficult to provide a more specific or useful description.*
FDA Label Image

Label (Lbl636291067)

Label (Lbl636291067)
This is a medication label for Spironolactone Tablets, USP with 50mg of Spironolactone, USP per tablet. The label includes information on dosage, storage instructions, and precautions, such as keeping the medication out of reach of children. The product is available in a container defined by USP, and the National Drug Code (NDC) is 63629-1067-1. This medication is available only with a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.